HWHG(SH:600079) Zheng Quan Zhi Xing·2025-07-10 10:11Core Viewpoint - The financial advisor, China Merchants Securities Co., Ltd., has verified the detailed equity change report of Renfu Pharmaceutical Group Co., Ltd., confirming that the disclosed content and format comply with regulations and that there are no false records, misleading statements, or significant omissions [1][6][9]. Summary by Sections Financial Advisor's Verification - The financial advisor conducted a thorough review of the detailed equity change report and confirmed that the information provided by the disclosing party is true, accurate, complete, and timely, with no significant omissions or misleading statements [2][6]. - The advisor's opinion is based on the assumption that the disclosing party has fully and timely fulfilled its obligations related to the transaction [2][3]. Disclosing Party's Information - The disclosing party, China Merchants Life Science (Wuhan) Co., Ltd., has a registered capital of 200 million RMB and is involved in medical research and development [7][12]. - The equity structure of the disclosing party shows that it is wholly owned by China Merchants Innovation Technology (Group) Co., Ltd. [12][15]. Equity Change Details - Following the signing of the agreement, the disclosing party and its affiliates will collectively hold 429,276,816 shares of the listed company, accounting for 26.30% of the total share capital [5][9]. - The trust plan "Chun Ni 1" was established to execute the restructuring plan of the company "Wuhan Contemporary Technology Industry Group Co., Ltd." and involves the transfer of 11.70% of Renfu Pharmaceutical's shares [9][10]. Financial Performance of Related Entities - Wuhan High-Tech State-owned Holding Group Co., Ltd. reported total assets of 994.47 billion RMB, total liabilities of 707.50 billion RMB, and a net profit of 1.54 billion RMB for the year 2024 [23][24]. - The financial data for China Merchants Group shows total assets of 28,751.03 billion RMB and a net profit of 786.16 million RMB for the year 2024 [25].